
MRNA Stock Up 10%, Moderna CEO Says Supply of Coronavirus Vaccine Will Be Limited
It has become known that the supply of Moderna’s coronavirus vaccine will be limited and the U.S. government will help to choose who will be the first to get it. Meanwhile, today Moderna (MRNA) stock is around 10% up.